CASE STUDY PARTNER WITH US COVID-19 CONTACT 1.888.521.7234 Leadership Team Philippe Lamarre CEO A Message from our CEO For most of us, we need to look no further than our own families to have been impacted by degenerative diseases, chronic health conditions, and cancers that often appear with a terminal prognosis. Yet, I hope that it is fair to say that for many of us, we have been lucky enough to have benefited from drugs, therapies, and products that have alleviated some or all of the debilitating characteristics of these ailments. I certainly have experienced the wonders of scientific progress in fighting disease and prolonging the quality life for loved ones, and count myself blessed to be part of a team of dedicated and caring individuals that participate in this medical progress. Mispro Biotech Services is in the enviable position of serving as a catalyst for such critical scientific research and development. Our core business of managed research environments enables biotech organizations to launch and control early-stage animal studies in stable & secure facilities without having to incur the costs of building or operating a private vivarium. Which allows for more organizations to launch studies for their discoveries, and when more scientists are at work, more advancements in health care can be made. Of this, we believe our business model makes both economic and scientific sense, and we are currently expanding our network of facilities to enable more organizations to pursue development of their therapeutic products. But it is our support of these organizations in the pursuit of good science that we are most proud, and from which Mispro operates its entire business model. Our managed facilities would not be as attractive an option for conducting early-stage development research without the expert animal care, compliance oversight, and operational excellence that we offer to our clients. Mispro also strongly supports and advocates for the ethical & humane treatment of research animals, and we are dedicated to pursuing, and ensuring, the 3R’s in every study conducted in our facilities & with our Insource services. Our clients are conducting important, powerful work, and Mispro is committed to being their most valuable research partner. Keith M. Astrofsky, DVM VICE PRESIDENT OF OPERATIONS & CAPITAL ASSET DEVELOPMENT As Vice President of Operations & Capital Asset Development, Dr. Astrofsky is responsible for managing Mispro’s daily operations, including facilities, staff, and services. Dr. Astrofsky has more than 20 years’ experience in veterinary & animal laboratory sciences, with expertise in animal care & welfare, program accreditation & compliance, animal model development, husbandry & technical procedures, and animal facility design. Prior to joining Mispro, Dr. Astrofsky was Executive Director & Global Head, Laboratory Animal Services (LAS) at Novartis Institutes for Biomedical Research (NIBR). Previous to that, he served as Attending Veterinarian & Head, Vivarium Operations with Praecis Pharmaceuticals, Inc. Dr. Astrofsky is an active member of several professional societies & committees and continues to serve in consulting, teaching, and advisory positions with several biotechnology, non-profit, and academic institutions. Dr. Astrofsky received his DVM from Tufts University School of Veterinary Medicine and completed a postdoctoral fellowship in comparative medicine at the Massachusetts Institute of Technology (MIT) in the laboratory of James G. Fox, DVM. Read More Yohan Tessier VICE PRESIDENT OF COMMERCIAL OPERATIONS & STRATEGIC DEVELOPMENT As Vice President of Commercial Operations & Strategic Development, Yohan is responsible for managing the Strategic Development, Sales & Marketing division of Mispro. Since 2007, Yohan has been on the forefront of Mispro’s growth from a single site in Montréal to the company’s current network of multiple facilities in key U.S. biotech clusters. With several years’ experience in big pharma and a background in science & healthcare, Yohan has an acute understanding of the challenges associated with drug development. His tireless enthusiasm for identifying opportunities & solutions to support the life sciences industry in the pursuit of drug therapies has been a cornerstone in establishing Mispro as a leader in space & services solutions for in-vivo science. Yohan recently completed the Executive MBA programs at ESG-UQAM/Paris –Dauphine universities and has also received a B.Sc. in Biochemistry from McGill University. Read More Denis Archambault CHIEF FINANCIAL OFFICER Kelly Perlangeli VICE PRESIDENT, HUMAN RESOURCES Anouk Laurent CORPORATE COUNSEL George Skourides Director of Business Development Bill Glencross Director of Sales John Fogarty Director of Marketing Moses Gutierrez RLATG, CMAR Associate Director of Operations Claire Johnson MS, CPIA Manager of Quality Assurance & Compliance; IACUC Chair Elizabeth Horrigan Manager of Technical Services Cristian Ramos Controller Alexandre Dame Director of Information Technology Yan Morin B.SC., RLAT Site Supervisor Benny Lapierre AS, ALAT Site Supervisor Edgar Castro AA, RLAT Site Supervisor Mark D. Snead BS, RALAT Site Supervisor Ryan Dominia AS, ALAT Site Supervisor All of Mispro Biotech Services locations are fully accredited by AAALAC International. Company About Us Leadership Team Ethics & Compliance News & Events Careers Services Vivarium Insourcing Services Science at Our Facilities Questions about any of our locations? Send us a message CONTACT US OR Call us directly at 1.888.521.7234 Between 8am to 5pm EST - Monday to Friday © 2021 MISPRO BIOTECH SERVICES. PRIVACY POLICY CASE STUDY PARTNER WITH US COVID-19 CONTACT